Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls

The 3 CYP450 Clinical Pearls Every Psychiatric Prescriber Should Know

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] CYP450 MADE SIMPLE: THE PSYCHIATRIC PRESCRIBER'S GUIDE TO DRUG INTERACTIONS, GENETICS & REAL-WORLD PEARLS Why does 10 mg of Prozac feel overwhelming for one patient—but barely touch another? Why does a patient suddenly develop akathisia after adding bupropion, or become toxic after quitting smoking? The answer often isn't the medication itself. It's the CYP450 enzyme system. In this episode of Pearls & Prep, Dr. Z breaks down one of the most intimidating topics in psychopharmacology into practical, memorable clinical pearls you can immediately use in practice. Whether you're a psychiatric NP, PA, physician, pharmacist, resident, or student, understanding CYP metabolism will dramatically improve your prescribing and help you avoid some of psychiatry's most common—and dangerous—drug interactions. You'll learn why some medications are "good neighbors" that play well with nearly every regimen, while others act like traffic jams that can dramatically raise drug levels. We'll also explain why genetics, smoking, grapefruit juice, age, liver disease, and even stopping cigarettes can completely change how psychiatric medications behave inside the body. Most importantly, you'll leave with a practical framework you can apply every single day in clinic instead of memorizing endless enzyme charts. IN THIS EPISODE YOU'LL LEARN * What the Cytochrome P450 (CYP450) enzyme system actually is—and why every psychiatric prescriber should understand it * The four CYP enzymes that matter most in psychiatry: CYP2D6, CYP2C19, CYP1A2, and CYP3A4 * Why genetics create poor, intermediate, normal, rapid, and ultrarapid metabolizers * How pharmacogenomic testing relates to real-world prescribing * The difference between a CYP substrate, inhibitor, and inducer * Why escitalopram, venlafaxine, desvenlafaxine, and mirtazapine are often excellent choices in complex polypharmacy * Which antidepressants are the strongest CYP2D6 inhibitors * Why bupropion (Wellbutrin) is one of psychiatry's most commonly overlooked CYP inhibitors * The dangerous bupropion + atomoxetine (Strattera) interaction every ADHD prescriber should know * Why fluoxetine and paroxetine can dramatically increase levels of many psychiatric medications * The high-risk fluvoxamine + clozapine interaction and why it can become life-threatening * How CYP interactions affect tamoxifen metabolism in breast cancer patients * Why CYP inhibition happens within days, while enzyme induction develops over weeks * How smoking induces CYP1A2 and lowers clozapine and olanzapine concentrations * Why patients admitted to smoke-free hospitals may suddenly become toxic on clozapine * How grapefruit juice can dramatically increase levels of medications metabolized by CYP3A4 * The impact of aging and liver disease on medication metabolism * Practical prescribing strategies to reduce adverse drug interactions in psychiatric practice CLINICAL PEARLS YOU'LL REMEMBER ✔️ Think genetics first when patients say every medication causes side effects. ✔️ Think ultrarapid metabolism when nothing seems to work. ✔️ Escitalopram isn't just effective—it plays nicely with almost everyone else. ✔️ Bupropion is a stealth CYP2D6 inhibitor. ✔️ Fluoxetine's interaction doesn't end when you stop fluoxetine. ✔️ Smoking changes clozapine—not nicotine. ✔️ Inhibitors act fast. Inducers take time. WHO SHOULD LISTEN? This episode is designed for: * Psychiatric Mental Health Nurse Practitioners (PMHNPs) * Psychiatry residents * Medical students * Physician assistants * Family medicine clinicians * Primary care providers * Clinical pharmacists * Psychiatry pharmacists * Psychiatric nurses * Psych NP students preparing for boards * Anyone wanting to understand psychopharmacology without memorizing endless charts KEYWORDS CYP450, cytochrome P450, psychopharmacology, psychiatric medication interactions, CYP2D6, CYP2C19, CYP1A2, CYP3A4, pharmacogenomics, PGx, drug metabolism, antidepressants, antipsychotics, SSRIs, SNRIs, bupropion, Wellbutrin, escitalopram, Lexapro, fluoxetine, Prozac, paroxetine, Paxil, sertraline, Zoloft, venlafaxine, Effexor, desvenlafaxine, Pristiq, atomoxetine, Strattera, clozapine, olanzapine, aripiprazole, Abilify, polypharmacy, smoking and clozapine, grapefruit juice interactions, CYP inhibitors, CYP inducers, psychiatric prescribing, medication side effects, pharmacology, psychiatry education, PMHNP boards, psych NP review, medication metabolism, psychiatric pharmacy. If this episode helped simplify CYP450 for you, subscribe, leave a review, and share it with another clinician. For visual learning tools, downloadable psychiatry graphics, medication pearls, and exclusive psychopharmacology resources, join the Pearls & Prep Patreon and take your prescribing confidence to the next level. 32 The 3 CYP450 Clinical Pearls Every Psychiatric Prescriber Should Know Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Why Two Patients on the Same SSRI Dose Can Have Opposite Outcomes: CYP Enzymes, Protein Binding & the Blood-Brain Barrier Explained Simply

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Why does 10 mg of Prozac help one patient tremendously while another barely notices a difference? In this episode of Pearls & Prep, we break down one of the most important—and misunderstood—concepts in psychopharmacology: why the exact same antidepressant dose can produce completely different clinical outcomes. Using simple, memorable analogies, you'll follow a medication's journey from the stomach to the brain and discover the three major barriers that determine whether it actually reaches its target: * CYP450 metabolism: Why some patients clear medications so quickly that little drug remains, while others metabolize them slowly and experience higher exposure or more adverse effects. * Protein binding: Why medications riding on plasma proteins are temporarily inactive—and why only the unbound ("free") drug can leave the bloodstream and reach tissues. * The blood-brain barrier: Why even after surviving metabolism and becoming free drug, medications still must cross the brain's protective barrier before producing therapeutic effects. We'll also answer practical questions every psychiatric clinician encounters: * Why doesn't the same antidepressant dose work for everyone? * When should you increase the dose versus switch medications? * How do CYP interactions change medication exposure? * Why do some patients experience side effects at very low doses? * Why can two patients taking identical doses have dramatically different responses? * What role do genetics, drug interactions, and pharmacokinetics play in treatment success? * How can understanding these principles improve medication selection and patient education? Whether you're a psychiatric nurse practitioner, psychiatry resident, physician assistant, pharmacist, medical student, or practicing clinician, this episode simplifies pharmacokinetics into concepts you'll actually remember—and use every day in clinical practice. By the end of this episode, you'll never look at "10 mg" the same way again. Key topics: fluoxetine (Prozac), SSRIs, antidepressants, CYP450 enzymes, CYP2D6, CYP2C19, pharmacokinetics, protein binding, free drug, blood-brain barrier, medication metabolism, psychiatric medication dosing, personalized psychiatry, psychopharmacology, medication response, dose optimization, treatment-resistant depression, psychiatric nurse practitioner education, psychiatry board review, psych NP students. Takeaways: * Understanding that 20 milligrams of Prozac isn't the same for everyone is crucial. * First pass metabolism plays a huge role in how medications affect different patients. * Genetic variations in liver enzymes can lead to drastically different medication responses. * The blood-brain barrier is like a bouncer for drugs, determining their effectiveness. * Protein binding can influence how much active medication is available for therapeutic effects. * Different patients might require different medications due to unique metabolic pathways. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Prozac * Zoloft * Lexapro * Effexor * Depakote * Ibuprofen 32 Why Two Patients on the Same SSRI Dose Can Have Opposite Outcomes: CYP Enzymes, Protein Binding & the Blood-Brain Barrier Explained Simply Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Why Your Meds ‘Aren’t Working (It’s Not What You Think)

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Today, we’re diving into the nitty-gritty of medication adherence with a case study of our friend Maria, who's struggling with her Zoloft. She’s been on it for a while but feels like it’s just not cutting it, and that’s where we come in, right? We're gonna break down the four essential questions to ask when a patient says their meds aren't doing the trick: Are they taking it? Is the dose right? Has enough time passed? And, is the diagnosis spot on? Spoiler alert: nearly half of patients don’t take their medications as prescribed, which could totally turn the tables on their treatment response. So, grab your favorite drink, kick back, and let’s unravel how we can become rockstar prescribers by nailing down these details! First up, we dive into the case of Maria, a (mock) 42-year-old woman grappling with generalized anxiety and major depressive disorder. She's been on Zoloft, but she’s not feeling the love from her meds—just a big ol' 'meh.' Her PHQ-9 score dropped a little, but she still feels like she’s dragging through molasses. We chat about the common mistake of jumping straight to stronger meds without really getting into the nitty-gritty of her situation. It’s like trying to fix a flat tire with a new engine; we need to figure out if she's actually taking her meds, if the dosage is right, and if she’s been on them long enough to see results. Spoiler: almost half of patients don’t stick to their medication routines, and it’s a real game-changer. We break down the four key principles to consider when a patient says their meds aren’t working: adherence, dosing, duration, and diagnosis. By the end, you’ll be armed with the insights to avoid the rookie mistakes that lead to more frustration for both you and your patients. This isn’t just about prescribing; it’s about understanding the whole picture and keeping our patients on the road to feeling better, not just throwing new pills at them and hoping for the best. Takeaways: * Patients often struggle with medication adherence, so it's crucial to understand why. It can be a game changer for treatment outcomes. * When a patient like Maria reports their meds aren't working, we must explore their adherence, dosage, and duration of treatment. * A drop in PHQ-9 scores can indicate progress, but we need to balance that with patients' subjective experiences to avoid misunderstandings. * Understanding the nuances of patient symptoms is key; what they call anxiety might be something else entirely, like ADHD-related overwhelm. Companies mentioned in this episode: * Npc * Zoloft * Prozac * Sertraline 27 Why Your Meds ‘Aren’t Working (It’s Not What You Think) Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Irritability Pearls: Avoiding the Most Common Clinical Mistakes

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] One of the most common—and most misunderstood—symptoms in psychiatry is irritability. Is it depression, generalized anxiety disorder (GAD), PTSD, ADHD, bipolar disorder, autism, poor sleep, or even a medication side effect? The answer matters, because treating irritability starts with identifying what's driving it. In this episode of Pearls and Prep, we break down the neuroscience of irritability in a practical, clinically useful way. Learn how the amygdala, prefrontal cortex, serotonin, dopamine, and norepinephrine interact to shape threat perception, frustration tolerance, emotional regulation, and impulsive behavior. We'll explain why irritability is often the brain's "threat alarm" rather than simply anger, and how different psychiatric disorders can produce the same symptom through very different mechanisms. You'll also learn why SSRIs—particularly sertraline (Zoloft)—have some of the strongest evidence for reducing irritability across multiple psychiatric conditions, when they may worsen symptoms, and how to think through medication selection in real-world practice. We discuss common diagnostic pitfalls, medication-induced irritability, sleep-related contributors, and practical clinical pearls you can immediately apply with patients. Whether you're a psychiatric nurse practitioner (PMHNP), psychiatry resident, physician assistant, medical student, therapist, or practicing clinician, this episode will help you better understand, diagnose, and treat irritability with greater confidence and precision. Topics covered: Irritability, psychiatry, psychopharmacology, SSRIs, sertraline (Zoloft), Prozac (fluoxetine), Lexapro (escitalopram), anxiety, depression, PTSD, ADHD, bipolar disorder, autism, amygdala, serotonin, dopamine, norepinephrine, prefrontal cortex, psychiatric medications, medication pearls, evidence-based psychiatry, psychiatric nurse practitioner education. 32 Irritability Pearls: Avoiding the Most Common Clinical Mistakes Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

The Good, the Bad & the Weird of Z-Drugs

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Today, we’re diving into the world of Z drugs, and trust me, it’s gonna be a chill chat about what these meds really do in the real world. Z drugs are those non-benzodiazepine hypnotics that seem like a safer bet, but they come with their own set of quirks. I’ll share my personal experiences on when and why to prescribe these puppies, ‘cause let’s be real, navigating insomnia treatment can feel like a game of chess sometimes. We’ll also explore the important distinction between Z drugs and their benzodiazepine cousins, with a sprinkle of humor because who doesn’t love a good laugh while we learn? So grab a comfy seat, kick back, and let’s get into the nitty-gritty of sleep medications! 32 The Good, the Bad & the Weird of Z-Drugs Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Z drugs are like the cool kids in the sleep medication world, but let’s be real—they come with their own set of quirks. Our chat dives into what Z drugs really are, how they're a bit less habit-forming than their benzodiazepine cousins, and why that’s a big deal when you're trying to help patients catch some Zs. I reminisce about my school days, chilling with my clinical instructor, and how those couch-side convos shaped my understanding of these meds. We go beyond the textbooks and get into real-life scenarios—like when patients come into your office after trying every other option under the sun. CBT-I might be the gold standard, but not every patient has the time, desire, or insurance to make it happen. So, what do you do when they’re at their wits' end? That’s where Z drugs strut their stuff, but with a side of caution. We’ll cover the need for good patient conversations about tolerance, rebound insomnia, and those pesky complex sleep behaviors that can pop up. So grab your favorite drink and let’s get into the nitty-gritty of prescribing Z drugs in the real world. So here’s the deal: we’re diving into the world of Z drugs, and let me tell you, it’s a wild ride! I take you through what these meds are all about, how they differ from the classic benzos, and why that matters when you’re trying to help folks catch some quality sleep. We’re all about those real-life stories here, so I’m sharing my own struggles and successes with patients who’ve tried everything under the sun before finally landing in my office. You know how it goes—some patients just can’t get their sleep act together, and they want a quick fix. Enter Z drugs! But before you start handing them out like candy, we’ll have a good old-fashioned heart-to-heart about the potential pitfalls, like developing tolerance and those bizarre sleep behaviors that can leave you scratching your head. Plus, we’ll chat about my go-to Z drug, Lunesta, and why I think it’s the bee’s knees for treating chronic insomnia. Spoiler alert: it’s all about the balance between efficacy and tolerability. So whether you’re a seasoned pro or just dipping your toes into the world of sleep meds, there’s something here for everyone! Takeaways: * Z drugs are not your typical sleep meds; they're a mix of pros and cons, but understanding their effects is key for safe prescribing. * In clinical practice, we often face patients who have tried everything, so knowing when to prescribe Z drugs is super important. * The differences between Z drugs and benzodiazepines matter; Z drugs are more targeted for sedation without the same level of addiction risk. * Lunesta stands out among Z drugs for its lower tolerance risk, making it a go-to for chronic insomnia patients. * Understanding the importance of slow-wave sleep helps us realize why Z drugs can be beneficial without the downsides of traditional benzos. * Education and communication with patients about the risks and benefits of Z drugs can enhance treatment outcomes and safety. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Lunesta * CBTI * American Academy of Sleep Medicine * Prozac * Adderall * Klonopin * Ambien * Sonata * Doxepin * Ramelteon * Trazodone This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy